TNFRSF10B and neoplasm: In this scenario, stabilized PD‐L1 has potential to suppress the activity of incoming cytotoxic T cells in tumor microenvironment (TME) and it will give survival advantage to DR5‐resistant tumor cells (Fig 3A).